Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Syngene International Ltd. ( (IN:SYNGENE) ) has provided an update.
Syngene International Ltd. has disclosed that it received an order dated March 13, 2026 from the National Faceless Assessment Centre under Section 270A of the Income-tax Act relating to Assessment Year 2018-19. The communication follows earlier tax proceedings in which certain expense disallowances of Rs. 2.78 crore were scrutinized and appealed by the company.
After Syngene’s appeal, the National Faceless Appeal Centre directed verification and relief of the disputed Rs. 2.78 crore, and the Assessing Officer subsequently allowed this relief in September 2025. In line with that outcome, the latest order drops the associated penalty proceedings, removing a potential tax liability overhang and bringing closure to this specific leg of the company’s AY 2018-19 tax dispute.
More about Syngene International Ltd.
Syngene International Ltd. is an India-based contract research, development and manufacturing organization serving global pharmaceutical, biotechnology and other life sciences companies. It operates integrated discovery, development and analytical services from its facilities in Bengaluru, supporting clients across regulated markets with outsourced R&D and related scientific services.
Average Trading Volume: 89,154
Technical Sentiment Signal: Sell
Current Market Cap: 169.7B INR
See more data about SYNGENE stock on TipRanks’ Stock Analysis page.